Refractory adult Coats disease treated with dexamethasone intravitreal implant: A case report.
Medicine (Baltimore)
; 99(20): e20249, 2020 May.
Article
de En
| MEDLINE
| ID: mdl-32443362
ABSTRACT
INTRODUCTION:
Coats disease is a sporadic, retinal vascular abnormality, causing blindness. Several interventional methods, including laser photocoagulation, have been proposed; however, the use of intravitreal dexamethasone in refractory Coats disease is not well described. PATIENT CONCERNS A 38-year-old man presented with a painless reduction in visual acuity in his right eye, commencing 15 days prior to initial assessment. DIAGNOSIS Clinical manifestations and multimodal imaging indicated Coats disease.INTERVENTIONS:
Retinal laser photocoagulation was performed in the nonperfused areas, 15 months later, the exudative retinal detachment, and macular edema remained, the patient was then treated with an intravitreal slow-release dexamethasone implant.OUTCOMES:
The exudative retinal detachment and macular edema had resolved, and the BCVA had also improved.CONCLUSION:
Dexamethasone intravitreal implantation was effective in treating refractory Coats disease.
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Sujet principal:
Dexaméthasone
/
Télangiectasie rétinienne
Limites:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Langue:
En
Journal:
Medicine (Baltimore)
Année:
2020
Type de document:
Article